Current approaches to the treatment of neurodegenerative diseases focus on alleviating cognitive and motor symptoms through the use of various pharmacological agents, including cholinesterase inhibitors, dopaminergic drugs, benzothiazoles, and NMDA receptor antagonists [2]. The gene discussed is BCHE; the disease is neurodegenerative disease.